Alan P. Fields

9.4k total citations · 1 hit paper
120 papers, 7.9k citations indexed

About

Alan P. Fields is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Alan P. Fields has authored 120 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 31 papers in Oncology and 23 papers in Cell Biology. Recurrent topics in Alan P. Fields's work include Protein Kinase Regulation and GTPase Signaling (49 papers), PI3K/AKT/mTOR signaling in cancer (25 papers) and Melanoma and MAPK Pathways (12 papers). Alan P. Fields is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (49 papers), PI3K/AKT/mTOR signaling in cancer (25 papers) and Melanoma and MAPK Pathways (12 papers). Alan P. Fields collaborates with scholars based in United States, Norway and Australia. Alan P. Fields's co-authors include Nicole R. Murray, Verline Justilien, E. Aubrey Thompson, Lee Jamieson, Nicole R. Murray, Roderick P. Regala, Barbara A. Hocevar, Larry J. Thompson, David J. Burns and W. Stratford May and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alan P. Fields

120 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protein kinase C isozymes and the regulation of diverse cell responses

2000 632 citations Alan P. Fields et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan P. Fields United States	54	6.1k	1.8k	1.4k	1.1k	612	120	7.9k
Juan Carlos Lacal Spain	54	5.7k 0.9×	1.8k 1.0×	1.0k 0.8×	1.8k 1.7×	660 1.1×	162	8.4k
Viji Shridhar United States	47	4.5k 0.7×	1.4k 0.8×	1.2k 0.9×	1.4k 1.3×	431 0.7×	126	7.2k
Erik Bruyneel Belgium	47	4.7k 0.8×	2.2k 1.2×	1.3k 0.9×	1.3k 1.2×	727 1.2×	123	7.3k
Tomohiko Maehama Japan	32	6.2k 1.0×	1.1k 0.6×	1.5k 1.1×	798 0.7×	937 1.5×	66	7.6k
Roya Khosravi‐Far United States	44	6.8k 1.1×	1.9k 1.0×	2.1k 1.6×	1.1k 1.0×	975 1.6×	80	8.7k
Norbert Kraut Austria	33	5.0k 0.8×	2.7k 1.5×	1.7k 1.3×	1.4k 1.3×	635 1.0×	72	7.2k
Ludger Hengst Germany	31	4.8k 0.8×	3.1k 1.7×	1.2k 0.9×	802 0.8×	465 0.8×	48	6.5k
Masatoshi Kitagawa Japan	46	5.9k 1.0×	2.7k 1.5×	1.0k 0.7×	1.8k 1.7×	514 0.8×	144	7.8k
Ningzhi Xu China	41	5.4k 0.9×	1.3k 0.7×	1.1k 0.8×	1.5k 1.4×	818 1.3×	158	7.4k
Philipp Kaldis United States	50	6.0k 1.0×	2.8k 1.5×	2.3k 1.7×	883 0.8×	598 1.0×	134	8.7k

Countries citing papers authored by Alan P. Fields

Since Specialization

Citations

This map shows the geographic impact of Alan P. Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan P. Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan P. Fields more than expected).

Fields of papers citing papers by Alan P. Fields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan P. Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan P. Fields. The network helps show where Alan P. Fields may publish in the future.

Co-authorship network of co-authors of Alan P. Fields

This figure shows the co-authorship network connecting the top 25 collaborators of Alan P. Fields. A scholar is included among the top collaborators of Alan P. Fields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan P. Fields. Alan P. Fields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xinyan, Krishna R. Kalari, Xiaojia Tang, et al.. (2023). Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer. npj Breast Cancer. 9(1). 101–101. 4 indexed citations

Yin, Ning, Capella Weems, Barath Shreeder, et al.. (2022). Protein kinase Cι mediates immunosuppression in lung adenocarcinoma. Science Translational Medicine. 14(671). eabq5931–eabq5931. 11 indexed citations

Jeganathan, Karthik B., Jake A. Kloeber, Brian A. Davies, et al.. (2020). FoxM1 insufficiency hyperactivates Ect2–RhoA–mDia1 signaling to drive cancer. Nature Cancer. 1(10). 1010–1024. 4 indexed citations

Jatoi, Aminah, Carmen Radecki Breitkopf, Nathan R. Foster, et al.. (2014). A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients. Oncology. 88(4). 208–213. 28 indexed citations

Wang, Yin, Kristen S. Hill, & Alan P. Fields. (2013). PKCι Maintains a Tumor-initiating Cell Phenotype That Is Required for Ovarian Tumorigenesis. Molecular Cancer Research. 11(12). 1624–1635. 60 indexed citations

Bamlet, William R., et al.. (2010). Protein Kinase Cι Is Required for Pancreatic Cancer Cell Transformed Growth and Tumorigenesis. Cancer Research. 70(5). 2064–2074. 88 indexed citations

Regala, Roderick P., et al.. (2009). Atypical Protein Kinase Cι Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis. Cancer Research. 69(19). 7603–7611. 82 indexed citations

Fields, Alan P., et al.. (2009). Protein Kinase Cβ Is an Effective Target for Chemoprevention of Colon Cancer. Cancer Research. 69(4). 1643–1650. 20 indexed citations

Regala, Roderick P., E. Aubrey Thompson, & Alan P. Fields. (2008). Atypical Protein Kinase Cι Expression and Aurothiomalate Sensitivity in Human Lung Cancer Cells. Cancer Research. 68(14). 5888–5895. 76 indexed citations

10.

Yu, Wangsheng, Nicole R. Murray, Capella Weems, et al.. (2003). Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis. Journal of Biological Chemistry. 278(13). 11167–11174. 65 indexed citations

11.

Sinđić, Aleksandra, et al.. (2001). Presence and Activation of Nuclear Phosphoinositide 3-Kinase C2β during Compensatory Liver Growth. Journal of Biological Chemistry. 276(21). 17754–17761. 44 indexed citations

12.

Lü, Ying, Lee Jamieson, Allan R. Brasier, & Alan P. Fields. (2001). NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival. Oncogene. 20(35). 4777–4792. 57 indexed citations

13.

Ray, Alpana, Alan P. Fields, & Bimal K. Ray. (2000). Activation of Transcription Factor SAF Involves Its Phosphorylation by Protein Kinase C. Journal of Biological Chemistry. 275(50). 39727–39733. 23 indexed citations

14.

Jamieson, Lee, Lee Carpenter, Trevor J. Biden, & Alan P. Fields. (1999). Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced Apoptosis. Journal of Biological Chemistry. 274(7). 3927–3930. 99 indexed citations

15.

Li, Qing, Venkita Subbulakshmi, Alan P. Fields, Nicole R. Murray, & Martha K. Cathcart. (1999). Protein Kinase Cα Regulates Human Monocyte O·2Production and Low Density Lipoprotein Lipid Oxidation. Journal of Biological Chemistry. 274(6). 3764–3771. 64 indexed citations

16.

Thompson, Larry J. & Alan P. Fields. (1996). βII Protein kinase c is required for the G2/M phase transition of cell cycle. The FASEB Journal. 10(6). 1 indexed citations

17.

Thompson, Larry J. & Alan P. Fields. (1996). βII Protein Kinase C Is Required for the G2/M Phase Transition of Cell Cycle. Journal of Biological Chemistry. 271(25). 15045–15053. 136 indexed citations

18.

Huntley, Clayton C., et al.. (1995). Human Parainfluenza Virus Type 3 Phosphoprotein: Identification of Serine 333 as the Major Site for PKC ζ Phosphorylation. Virology. 211(2). 561–567. 25 indexed citations

19.

Fields, Alan P. & Larry J. Thompson. (1995). The regulation of mitotic nuclear envelope breakdown: A role for multiple lamin kinases. PubMed. 1. 271–286. 33 indexed citations

20.

Misra-Press, A., Alan P. Fields, David Samols, & David A. Goldthwait. (1992). Protein kinase C isoforms in human glioblastoma cells. Glia. 6(3). 188–197. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact